Blood Tests & Biomarkers

Taking creatine before a kidney blood test: what to tell your clinician

Creatine can complicate interpretation of creatinine. Learn what to disclose and why an abnormal kidney result should never be dismissed on your own.

A man bringing a plain supplement container to a discussion with a clinician.

Tell the clinician ordering a kidney blood test if you take creatine. Creatinine, the blood marker used in many kidney assessments, is not the supplement itself, and its interpretation can be affected by factors beyond kidney filtration. An abnormal result still needs assessment; “I take creatine” is context, not a diagnosis (MedlinePlus).

Cover illustration: Bring the actual label and your use history. The pictured container is an illustration and does not identify a product.

What the lab is measuring

Creatinine is a waste product linked to muscle activity. Healthy kidneys remove it from the blood. A blood result can help estimate glomerular filtration rate, or eGFR, but age, muscle-related factors, diet and other circumstances also affect interpretation. MedlinePlus advises discussing medicines and supplements and following the clinician's preparation instructions (MedlinePlus).

Your report may therefore include both creatinine and an estimated filtration rate derived from it. These are not two fully independent pieces of evidence. Take the complete report, with its units and earlier results, to the discussion rather than focusing on a flagged number alone.

What creatine research can tell you

A small randomized trial in healthy active young men assessed creatine use for 35 days. It found no between-group evidence of kidney injury in the measured markers. Within the creatine groups, changes in creatinine and calculated eGFR illustrated why those results need context (2020 trial).

That study does not establish safety for every dose, product or person with kidney disease. It also cannot prove that your own abnormal result is harmless. Our creatine guide covers the broader supplement evidence; the present question is how to disclose its use during an assessment.

Make the disclosure specific

Write down the product, amount you actually take, how long you have used it and any recent changes. Mention a loading phase if you used one, recent hard exercise and all other supplements or medicines. Bring a label photo if the product combines several ingredients.

Ask whether the clinician wants you to continue, pause or change anything before testing. Do not choose a fixed washout interval from a forum, and do not stop prescribed medicines on your own. If a result is already abnormal, seek interpretation instead of delaying care while you try to make the next number look better.

Kidney assessment is broader than one blood value

NIDDK describes kidney assessment using a blood estimate of filtration together with urine testing for albumin. An abnormal result may need confirmation and assessment of the wider history. Kidney disease can be present without symptoms, so feeling well does not rule it out (NIDDK).

Ask which result needs follow-up and when, and whether a different marker would clarify the picture in your situation. New swelling, a marked fall in urine output or feeling seriously unwell should prompt medical advice rather than another supplement experiment. Keep the plan in writing so future tests are compared under understood conditions.

Frequently asked questions

Can I assume a high creatinine result is just my supplement?

No. Creatine use is relevant context, but an abnormal result still needs assessment for kidney disease and other possible explanations.

Should I stop creatine for a fixed number of days before testing?

There is no universal interval this article can prescribe. Tell the ordering clinician what you take and follow the preparation plan they give you.

References

  1. Creatinine Test · MedlinePlus
  2. Chronic Kidney Disease Tests and Diagnosis · National Institute of Diabetes and Digestive and Kidney Diseases
  3. Novel renal biomarkers show that creatine supplementation is safe: a double-blind, placebo-controlled randomized clinical trial · Toxicology Research, 2020